Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in Peripheral Neuropathic Pain
2018-003110-40Phase 2Terminated
- Sponsor
- Aarhus University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral neuropathic pain comparing Lacosamide with Placebo (2 arms). Primary endpoint: Change in average pain intensity from baseline. Started Aug 2018; status: terminated.
02
Drugs
lacosamide
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on 2018-003110-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003110-40.